.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKesson
Teva
Daiichi Sankyo
AstraZeneca
Cipla
Julphar
US Army
US Department of Justice
Fish and Richardson

Generated: July 20, 2017

DrugPatentWatch Database Preview

CARDIZEM Drug Profile

« Back to Dashboard

Which patents cover Cardizem, and what generic Cardizem alternatives are available?

Cardizem is a drug marketed by Valeant Intl, Biovail Labs Intl, and Biovail. and is included in six NDAs. There are two patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in CARDIZEM is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

Summary for Tradename: CARDIZEM

Patents:0
Applicants:3
NDAs:6
Suppliers / Packagers: see list3
Bulk Api Vendors: see list31
Clinical Trials: see list9
Patent Applications: see list2,050
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARDIZEM at DailyMed

Pharmacology for Tradename: CARDIZEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail
CARDIZEM SR
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019471-004Jan 23, 1989DISCNYesNo► Subscribe► Subscribe
Valeant Intl
CARDIZEM
diltiazem hydrochloride
TABLET;ORAL018602-001Nov 5, 1982ABRXYesNo► Subscribe► Subscribe
Valeant Intl
CARDIZEM LA
diltiazem hydrochloride
TABLET, EXTENDED RELEASE;ORAL021392-003Feb 6, 2003ABRXYesNo7,108,866► SubscribeY ► Subscribe
Valeant Intl
CARDIZEM LA
diltiazem hydrochloride
TABLET, EXTENDED RELEASE;ORAL021392-006Feb 6, 2003ABRXYesYes7,108,866► SubscribeY ► Subscribe
Biovail
CARDIZEM
diltiazem hydrochloride
INJECTABLE;INJECTION020792-001Sep 5, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CARDIZEM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl
CARDIZEM
diltiazem hydrochloride
TABLET;ORAL018602-004Dec 8, 19863,706,789► Subscribe
Valeant Intl
CARDIZEM
diltiazem hydrochloride
TABLET;ORAL018602-004Dec 8, 19863,778,506► Subscribe
Valeant Intl
CARDIZEM
diltiazem hydrochloride
TABLET;ORAL018602-001Nov 5, 19823,562,257► Subscribe
Valeant Intl
CARDIZEM
diltiazem hydrochloride
TABLET;ORAL018602-003Dec 8, 19863,562,257► Subscribe
Valeant Intl
CARDIZEM
diltiazem hydrochloride
TABLET;ORAL018602-004Dec 8, 19863,562,257► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: CARDIZEM

Drugname Dosage Strength RLD Submissiondate
diltiazem hydrochlorideExtended-release Tablets120 mg, 180 mg, 240 mg, 300 mg and 360 mgCardizem LA8/30/2005
diltiazem hydrochlorideExtended-release Tablets420 mgCardizem LA4/25/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Farmers Insurance
Argus Health
UBS
Fuji
Julphar
US Army
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot